Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 4, 2026, 9:49 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 265–288 of 620 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Diabetes Risk Clear all

Conditions: Diabetes Mellitus, Obesity-Related Malignant Neoplasm
Interventions: Behavioral Intervention, Questionnaire Administration; Behavioral · Other
Lead sponsor: City of Hope Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 347 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2027
U.S. locations: 1
States / cities: Duarte, California

Conditions: Diabetes
Interventions: Diabetes Medication Choice Decision Aid, Statin Choice Decision Aid, Usual care for lipid therapy medication, Usual care for antihyperglycemic medication; Other
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 110 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2013
U.S. locations: 5
States / cities: Albert Lea, Minnesota • Austin, Minnesota • Kasson, Minnesota + 1 more

Conditions: Diabetes Mellitus, Type 2
Interventions: Not listed
Lead sponsor: VeraLight, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 3,478 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2010
U.S. locations: 15
States / cities: Huntsville, Alabama • San Diego, California • Washington D.C., District of Columbia + 11 more

Conditions: Type 2 Diabetes
Interventions: integrated program of nutrition, activity, behavior, and promotion; Behavioral
Lead sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); NIH
Eligibility: 10 Years to 16 Years
Enrollment: 4,603 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2011
U.S. locations: 8
States / cities: Irvine, California • Rockville, Maryland • Chapel Hill, North Carolina + 5 more

Conditions: Diabetes, Neuropathic Limb, Elevated Temperature, Shear Pressure, Increased Temperatures
Interventions: TempTouchRM, Offloading; Device
Lead sponsor: Diabetica Solutions Inc.; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 110 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2008
U.S. locations: 1
States / cities: San Antonio, Texas

Conditions: Type 1 Diabetes Mellitus
Interventions: Insulin Degludec, Insulin Glargine; Drug
Lead sponsor: Yale University; Other
Eligibility: 8 Years to 18 Years
Enrollment: 32 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2021
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Sleep, Diabetes
Interventions: baseline study; Behavioral
Lead sponsor: University of Chicago; Other
Eligibility: 18 Years to 20 Years
Enrollment: 5 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2010
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Cardiovascular Diseases, Diabetes Mellitus, Type 2
Interventions: 3-month Exercise Training and Diet Education; Behavioral
Lead sponsor: University of San Francisco; Other
Eligibility: 45 Years to 75 Years · Female only
Enrollment: 35 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2007
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Obesity, Overweight, Cardiovascular Diseases, Diabetes Mellitus, Type 2
Interventions: Eloralintide, Placebo; Drug
Lead sponsor: Eli Lilly and Company; Industry
Eligibility: 45 Years and older
Enrollment: 3,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 70
States / cities: Birmingham, Alabama • Huntsville, Alabama • Apache Junction, Arizona + 61 more

Conditions: PreDiabetes, Aging
Interventions: Moderate Intensity Exercise Training (MOD), Vigorous Intensity Exercise Training (VIG); Behavioral
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 60 Years to 79 Years
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Diabetes Mellitus, Hypertension, Dyslipidemias
Interventions: Comprehensive Unit Based Safety Program (CUSP); Other
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years and older
Enrollment: 85 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Diabetes Mellitus, Type 2, Prediabetic State, Sleep Initiation and Maintenance Disorders
Interventions: SHUTi, Patient Education; Other
Lead sponsor: Kaiser Permanente; Other
Eligibility: 22 Years to 79 Years
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Atherosclerotic Cardiovascular Disease, Familial Hypercholesterolemia, Diabetes
Interventions: ALN-PCSSC, Normal Saline; Drug
Lead sponsor: The Medicines Company; Industry
Eligibility: 18 Years to 99 Years
Enrollment: 501 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 8
States / cities: Jacksonville, Florida • Indianapolis, Indiana • New York, New York + 4 more

Conditions: Child Development, Mother-Infant Interaction, Diabetes Mellitus, Gestational
Interventions: Family Nurture Intervention (FNI); Behavioral
Lead sponsor: Columbia University; Other
Eligibility: 12 Hours to 3 Days
Enrollment: 4 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020
U.S. locations: 1
States / cities: New York, New York

Conditions: Cardiometabolic Risk Factors, Diabetes, High Blood Pressure, Obesity, Nutrition Security
Interventions: Food is Medicine; Other
Lead sponsor: Tufts University; Other
Eligibility: 21 Years and older
Enrollment: 300 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Diabetes Mellitus Self Management Education, Hyperglycemic Control, High Risk Diabetes
Interventions: Diabetes Self Management Education; Behavioral
Lead sponsor: US Department of Veterans Affairs; Federal
Eligibility: 18 Years and older
Enrollment: 1,800 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Ends 2002
U.S. locations: 1
States / cities: Atlanta, Kansas

Conditions: Cholesterol, Elevated, Diabetes Mellitus
Interventions: Guided management, Self management; Other
Lead sponsor: University of Oklahoma; Other
Eligibility: 18 Years to 39 Years
Enrollment: 360 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2029
U.S. locations: 1
States / cities: Oklahoma City, Oklahoma

Conditions: Prediabetic State
Interventions: Oral glucose tolerance test; Other
Lead sponsor: University of Florida; Other
Eligibility: 18 Years to 65 Years
Enrollment: 26 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Gestational Diabetes Mellitus, Pregnancy
Interventions: Not listed
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years to 40 Years · Female only
Enrollment: 88 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2014
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Type 2 Diabetes Mellitus, Obesity, Overweight
Interventions: Semaglutide, Dulaglutide; Drug
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years and older
Enrollment: 120,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Type 2 Diabetes
Interventions: Dexcom G6 Continous Glucose Monitoring Management, Usual Care - Blinded Continuous Glucose Monitoring Management; Device
Lead sponsor: Scripps Whittier Diabetes Institute; Other
Eligibility: 18 Years and older
Enrollment: 518 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: Chula Vista, California

Conditions: Gestational Diabetes Mellitus in Pregnancy
Interventions: Continuous Glucose Monistor; Device
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 18 Years and older · Female only
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2030
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Obesity, Overweight, Diabetes
Interventions: Cell Phone, Weekly access to interactive web site, Group; Behavioral
Lead sponsor: University of California, San Diego; Other
Eligibility: 12 Years to 16 Years
Enrollment: 101 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2009
U.S. locations: 1
States / cities: La Jolla, California

Conditions: Type 1 Diabetes
Interventions: Ramipril, Placebo; Drug
Lead sponsor: Northwestern University; Other
Eligibility: 13 Years to 50 Years
Enrollment: 65 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2010
U.S. locations: 6
States / cities: Gainesville, Florida • Chicago, Illinois • Maywood, Illinois

Search by objective public record fields.

Eat, Move, Live Program for the Reduction of Cancer and Chronic Disease Risk in Underserved Communities

Impact of Decision Aids to Enhance Shared Decision Making for Diabetes

Screening for Early Evidence of Diabetes

Middle-School Based Primary Prevention Trial of Type 2 Diabetes

Novel Home Care Device for High-Risk Diabetic Patients

Reducing the Risk of Metabolic Decompensation in Diabetic Adolescents by Supervised School Administration of Insulin

Individual Differences in Diabetes Risk: Role of Slow WaveSleep

Exercise Training in Older Diabetic Women

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, Type 2 Diabetes, and Increased Cardiovascular Risk

Effects of Progressive Intensity Exercise Training on Glycemic Control in Older Adults

A Quality Improvement Process to Support Delivery of Cardiovascular Care in Community Mental Health Organizations

Sleep for Health Study on the Effects of Cognitive Behavioral Therapy for Insomnia on Diabetes Risk

Trial to Evaluate the Effect of ALN-PCSSC Treatment on Low Density Lipoprotein Cholesterol (LDL-C)

Clinical Interventions to Mitigate Neurodevelopmental Risk

Delta GREENS Food is Medicine Intervention

Disease Management and Educational Intervention Outcomes in High-Risk Diabetics

Community Intervention to Improve CVD Risk Factor Control in Young American Indians

Antihypertensive Medication Exposure as Risk for Impaired Glucose Tolerance: A PEAR Sub-Study

Gestational Diabetes Mellitus and Cardiovascular Disease: The Role of Vascular Dysfunction

Injectable Semaglutide vs Dulaglutide in Individuals at Cardiovascular Risk

Continuous Glucose Monitoring for High-Risk Type 2 Diabetes in the Hospital (Cyber GEMS)

Postpartum Continuous Glucose Monitoring for Type 2 Diabetes Mellitus Risk Evaluation in Patients With Gestational Diabetes Mellitus: POSTPOD Trial

PACE-iDP: An Intervention for Youth at Risk for Diabetes

PREVENTKD (Prevent Risks by Early interVEntion at Nighttime in Type 1 Diabetes for Kidney Disease)